Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Gardner

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2021
Impact of HIV-1 Infection and Antigen Class on T Follicular Helper Cell Responses to Pneumococcal Polysaccharide-Protein Conjugate Vaccine-13Vibha Jha, Lindsay K Nicholson, Edward M Gardner, et al.
HIV Research & Clinical Practice|June 4, 2024
Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIVArianna E Kousari, Melissa P Wilson, Kellie L Hawkins, et al.
The Journal of Infectious Diseases|May 8, 2024
Clinical and Microbial Determinants of Upper Respiratory Colonization With Streptococcus pneumoniae and Native Microbiota in People With Human Immunodeficiency Virus Type 1 and Control AdultsLindsay K Nicholson, Jennifer M Kofonow, Charles E Robertson, et al.
Journal of General Internal Medicine|January 31, 2018
Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid TherapyJason M Glanz, Komal J Narwaney, Shane R Mueller, et al.
Respiration; International Review of Thoracic Diseases|August 10, 2005
A middle-aged woman with recurrent respiratory infectionsKathryn Chmura, Edward D Chan, Peadar G Noone, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2009
Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressorsPeter L Anderson, Christina L Aquilante, Edward M Gardner, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary CareIngrid A Binswanger, Nicole Joseph, Rebecca Hanratty, et al.
AIDS Research and Human Retroviruses|June 11, 2015
Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir RegimenAmie L Meditz, Claire Palmer, Julie Predhomme, et al.
Open Forum Infectious Diseases|November 19, 2019
Corticosteroids for Posttransplant Immune Reconstitution Syndrome in <i>Cryptococcus gattii</i> Meningoencephalitis: Case Report and Literature ReviewGregory S Canfield, Andrés F Henao-Martínez, Carlos Franco-Paredes, et al.
Infectious Disorders Drug Targets|March 17, 2011
HIV treatment adherence, drug resistance, virologic failure: evolving conceptsJean B Nachega, Vincent C Marconi, Gert U van Zyl, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2021
Impact of HIV-1 Infection and Antigen Class on T Follicular Helper Cell Responses to Pneumococcal Polysaccharide-Protein Conjugate Vaccine-13Vibha Jha, Lindsay K Nicholson, Edward M Gardner, et al.
HIV Research & Clinical Practice|June 4, 2024
Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIVArianna E Kousari, Melissa P Wilson, Kellie L Hawkins, et al.
The Journal of Infectious Diseases|May 8, 2024
Clinical and Microbial Determinants of Upper Respiratory Colonization With Streptococcus pneumoniae and Native Microbiota in People With Human Immunodeficiency Virus Type 1 and Control AdultsLindsay K Nicholson, Jennifer M Kofonow, Charles E Robertson, et al.
Journal of General Internal Medicine|January 31, 2018
Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid TherapyJason M Glanz, Komal J Narwaney, Shane R Mueller, et al.
Respiration; International Review of Thoracic Diseases|August 10, 2005
A middle-aged woman with recurrent respiratory infectionsKathryn Chmura, Edward D Chan, Peadar G Noone, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2009
Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressorsPeter L Anderson, Christina L Aquilante, Edward M Gardner, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary CareIngrid A Binswanger, Nicole Joseph, Rebecca Hanratty, et al.
AIDS Research and Human Retroviruses|June 11, 2015
Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir RegimenAmie L Meditz, Claire Palmer, Julie Predhomme, et al.
Open Forum Infectious Diseases|November 19, 2019
Corticosteroids for Posttransplant Immune Reconstitution Syndrome in <i>Cryptococcus gattii</i> Meningoencephalitis: Case Report and Literature ReviewGregory S Canfield, Andrés F Henao-Martínez, Carlos Franco-Paredes, et al.
Infectious Disorders Drug Targets|March 17, 2011
HIV treatment adherence, drug resistance, virologic failure: evolving conceptsJean B Nachega, Vincent C Marconi, Gert U van Zyl, et al.
Pageof 8